🇺🇸 FDA
Patent

US 6974797

Cross-linked glycopeptide-cephalosporin antibiotics

expired A61KA61K31/545A61K38/00

Quick answer

US patent 6974797 (Cross-linked glycopeptide-cephalosporin antibiotics) held by Theravance, Inc. expires Mon Dec 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Dec 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/545, A61K38/00, A61P, A61P31/00